Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors

Seminars in Interventional Radiology

Volumn 31, Issue 2, 2014, Pages 129-137

  Yu, Hyeon ^a   Burke, Charles T ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

cryoablation; high intensity focused ultrasound ablation; interventional radiology; irreversible electroporation; microwave ablation; percutaneous chemical ablation; radiofrequency ablation

Indexed keywords

ACETIC ACID; ALCOHOL; SODIUM HYDROXIDE;

ABLATION THERAPY; ABSCESS; ARTICLE; BILE DUCT INJURY; CANCER RECURRENCE; CANCER STAGING; CHEMICAL REACTION; CHEMOEMBOLIZATION; CRYOABLATION; CYTOTOXICITY; DIRECT CURRENT; DISEASE FREE SURVIVAL; ELECTRIC POTENTIAL; ELECTRODE; ELECTROPORATION; HEART ARRHYTHMIA; HEMOPERITONEUM; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTESTINE PERFORATION; IRREVERSIBLE ELECTROPORATION; LASER SURGERY; LIVER CELL CARCINOMA; LOCAL RECURRENCE FREE SURVIVAL; MICROWAVE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PANCREATITIS; PATIENT SAFETY; PERCUTANEOUS CHEMICAL ABLATION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SPONTANEOUS PNEUMOTHORAX; SURVIVAL RATE; SURVIVAL TIME; TEMPERATURE; TISSUE PRESSURE; TUMOR ABLATION; ULTRASOUND TRANSDUCER;

EID: 84901342779     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0034-1373788     Document Type: Article

References (97)

1. Stigliano R., Marelli L., Yu D., Davies N., Patch D., Burroughs A. K. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev: 2007; 33 5 437 447 (Pubitemid 47324228)
2. Clark T. W., Soulen M. C. Chemical ablation of hepatocellular carcinoma. J Vasc Interv Radiol: 2002; 13 9, Pt 2 S245 S252
3. Shiina S., Tagawa K., Niwa Y., et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol: 1993; 160 5 1023 1028 (Pubitemid 23141242)
4. Lencioni R., Bartolozzi C., Caramella D., et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer: 1995; 76 10 1737 1746
5. Livraghi T., Giorgio A., Marin G., et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology: 1995; 197 1 101 108
6. Da Ines D., Buc E., Petitcolin V., et al. Massive hepatic necrosis with gastric, splenic, and pancreatic infarctions after ethanol ablation for hepatocellular carcinoma. J Vasc Interv Radiol: 2010; 21 8 1301 1305
7. Hasegawa S., Yamasaki N., Hiwaki T., et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer: 1999; 86 9 1682 1690 (Pubitemid 29513036)
8. McWilliams J. P., Yamamoto S., Raman S. S., et al. Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol: 2010; 21 (8, Suppl): S204 S213
9. Shiina S., Teratani T., Obi S., et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology: 2005; 129 1 122 130 (Pubitemid 41002049)
10. Lin S. M., Lin C. J., Lin C. C., Hsu C. W., Chen Y. C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology: 2004; 127 6 1714 1723
11. Lencioni R. A., Allgaier H. P., Cioni D., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology: 2003; 228 1 235 240 (Pubitemid 36736097)
12. Cho Y. K., Kim J. K., Kim M. Y., Rhim H., Han J. K. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology: 2009; 49 2 453 459
13. Orlando A., Leandro G., Olivo M., Andriulli A., Cottone M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol: 2009; 104 2 514 524
14. Shiina S., Tagawa K., Unuma T., et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer: 1991; 68 7 1524 1530
15. Swabb E. A., Wei J., Gullino P. M. Diffusion and convection in normal and neoplastic tissues. Cancer Res: 1974; 34 10 2814 2822
16. Ohnishi K., Ohyama N., Ito S., Fujiwara K. Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology: 1994; 193 3 747 752 (Pubitemid 24366946)
17. Ohnishi K., Nomura F., Ito S., Fujiwara K. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. Hepatology: 1996; 23 5 994 1002 (Pubitemid 26137038)
18. Ohnishi K., Yoshioka H., Ito S., Fujiwara K. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology: 1998; 27 1 67 72 (Pubitemid 28041536)
19. Tamai T., Seki T., Imamura M., et al. Percutaneous injection of a low-concentration alkaline solution targeting hepatocellular carcinoma. Oncol Rep: 2000; 7 4 719 723
20. Farnam J. L., Smith B. C., Johnson B. R., et al. Thermochemical ablation in an ex-vivo porcine liver model using acetic acid and sodium hydroxide: proof of concept. J Vasc Interv Radiol: 2010; 21 10 1573 1578
21. Rubinsky B., Onik G., Mikus P. Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat: 2007; 6 1 37 48 (Pubitemid 46389347)
22. Davalos R. V., Mir I. L., Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng: 2005; 33 2 223 231 (Pubitemid 40496051)
23. Miller L., Leor J., Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat: 2005; 4 6 699 705 (Pubitemid 43083355)
24. Edd J. F., Horowitz L., Davalos R. V., Mir L. M., Rubinsky B. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng: 2006; 53 7 1409 1415 (Pubitemid 44172315)
25. Melikov K. C., Frolov V. A., Shcherbakov A., Samsonov A. V., Chizmadzhev Y. A., Chernomordik L. V. Voltage-induced nonconductive pre-pores and metastable single pores in unmodified planar lipid bilayer. Biophys J: 2001; 80 4 1829 1836 (Pubitemid 32280998)
26. Lee E. W., Chen C., Prieto V. E., Dry S. M., Loh C. T., Kee S. T. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology: 2010; 255 2 426 433
27. Thomson K. R., Cheung W., Ellis S. J., et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol: 2011; 22 5 611 621
28. Narayanan G., Hosein P. J., Arora G., et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol: 2012; 23 12 1613 1621
29. Kingham T. P., Karkar A. M., D'Angelica M. I., et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. J Am Coll Surg: 2012; 215 3 379 387
30. Silk M. T., Wimmer T., Lee K. S., et al. Percutaneous ablation of peribiliary tumors with irreversible electroporation. J Vasc Interv Radiol: 2014; 25 1 112 118
31. Cannon R., Ellis S., Hayes D., Narayanan G., Martin R. C. II. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol: 2013; 107 5 544 549
32. Ng K. K., Poon R. T., Chan S. C., et al. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg: 2011; 253 5 981 987
33. Wu F., Wang Z. B., Chen W. Z., et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem: 2004; 11 3-4 149 154 (Pubitemid 38479821)
34. Lynn J. G., Zwemer R. L., Chick A. J., Miller A. E. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol: 1942; 26 2 179 193
35. Shen H. P., Gong J. P., Zuo G. Q. Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma. Am Surg: 2011; 77 11 1496 1501
36. Mearini L., Porena M. Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future. Indian J Urol: 2010; 26 1 4 11
37. Kennedy J. E., Ter Haar G. R., Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol: 2003; 76 909 590 599
38. Zhu J., Zhu H., Mei Z., et al. High-intensity focused ultrasound ablation for treatment of hepatocellular carcinoma and hypersplenism: preliminary study. J Ultrasound Med: 2013; 32 10 1855 1862
39. Hesley G. K., Gorny K. R., Woodrum D. A. MR-guided focused ultrasound for the treatment of uterine fibroids. Cardiovasc Intervent Radiol: 2013; 36 1 5 13
40. Mearini L. High intensity focused ultrasound, liver disease and bridging therapy. World J Gastroenterol: 2013; 19 43 7494 7499
41. Xu G., Luo G., He L., et al. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma. Ultrasound Med Biol: 2011; 37 12 1993 1999
42. Zhang L., Zhu H., Jin C., et al. High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol: 2009; 19 2 437 445
43. Cheung T. T., Fan S. T., Chu F. S., et al. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma. HPB (Oxford): 2013; 15 8 567 573
44. Pacella C. M., Bizzarri G., Cecconi P., et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology: 2001; 219 3 669 678 (Pubitemid 32476256)
45. Wu F., Wang Z. B., Chen W. Z., et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology: 2005; 235 2 659 667 (Pubitemid 40571111)
46. Jin C., Zhu H., Wang Z., et al. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis. Eur J Radiol: 2011; 80 3 662 669
47. Vaezy S., Martin R., Keilman G., et al. Control of splenic bleeding by using high intensity ultrasound. J Trauma: 1999; 47 3 521 525 (Pubitemid 29444390)
48. Noble M. L., Vaezy S., Keshavarzi A., et al. Spleen hemostasis using high-intensity ultrasound: survival and healing. J Trauma: 2002; 53 6 1115 1120 (Pubitemid 35435104)
49. Shi B., Zhu H., Liu Y. J., et al. Experimental studies and clinical experiences on treatment of secondary hypersplenism with extracorporeal high-intensity focused ultrasound. Ultrasound Med Biol: 2012; 38 11 1911 1917
50. Pacella C. M., Francica G., Di Costanzo G. G. Laser ablation for small hepatocellular carcinoma. Radiol Res Pract: 2011; 2011 595627
51. Masters A., Bown S. G. Interstitial laser hyperthermia in tumour therapy. Ann Chir Gynaecol: 1990; 79 4 244 251
52. Thomsen S. Pathologic analysis of photothermal and photomechanical effects of laser-tissue interactions. Photochem Photobiol: 1991; 53 6 825 835
53. Jacques S. L. Laser-tissue interactions. Photochemical, photothermal, and photomechanical. Surg Clin North Am: 1992; 72 3 531 558
54. Di Costanzo G. G., D'Adamo G., Tortora R., et al. A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique. Acta Radiol: 2013; 54 8 876 881
55. Bown S. G. Phototherapy in tumors. World J Surg: 1983; 7 6 700 709
56. Wyman D. R., Whelan W. M., Wilson B. C. Interstitial laser photocoagulation: Nd:YAG 1064. nm optical fiber source compared to point heat source. Lasers Surg Med: 1992; 12 6 659 664
57. Germer C. T., Roggan A., Ritz J. P., et al. Optical properties of native and coagulated human liver tissue and liver metastases in the near infrared range. Lasers Surg Med: 1998; 23 4 194 203 (Pubitemid 28523525)
58. Ritz J. P., Roggan A., Germer C. T., Isbert C., Müller G., Buhr H. J. Continuous changes in the optical properties of liver tissue during laser-induced interstitial thermotherapy. Lasers Surg Med: 2001; 28 4 307 312 (Pubitemid 32411110)
59. Tranberg K. G. Percutaneous ablation of liver tumours. Best Pract Res Clin Gastroenterol: 2004; 18 1 125 145
60. Pacella C. M., Bizzarri G., Francica G., et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol: 2005; 16 11 1447 1457 (Pubitemid 43017688)
61. Arienti V., Pretolani S., Pacella C. M., et al. Complications of laser ablation for hepatocellular carcinoma: a multicenter study. Radiology: 2008; 246 3 947 955
62. Puls R., Langner S., Rosenberg C., et al. Laser ablation of liver metastases from colorectal cancer with MR thermometry: 5-year survival. J Vasc Interv Radiol: 2009; 20 2 225 234
63. Orlacchio A., Bolacchi F., Chegai F., et al. Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm. Radiol Med (Torino): 2013
64. Zou X., Liu Q., Zhou X., et al. Ultrasound-guided percutaneous laser and ethanol ablation of rabbit VX2 liver tumors. Acta Radiol: 2013; 54 2 181 187
65. Chen M. S., Li J. Q., Zheng Y., et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg: 2006; 243 3 321 328 (Pubitemid 43327762)
66. McGahan J. P., Browning P. D., Brock J. M., Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol: 1990; 25 3 267 270 (Pubitemid 20085776)
67. Buscarini E., Savoia A., Brambilla G., et al. Radiofrequency thermal ablation of liver tumors. Eur Radiol: 2005; 15 5 884 894 (Pubitemid 41166720)
68. Brace C. L. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol: 2009; 38 3 135 143
69. Nicoli N., Casaril A., Marchiori L., et al. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma. Chir Ital: 2000; 52 1 29 40
70. Grasso A., Watkinson A. F., Tibballs J. M., Burroughs A. K. Radiofrequency ablation in the treatment of hepatocellular carcinoma-a clinical viewpoint. J Hepatol: 2000; 33 4 667 672
71. Dong B., Liang P., Yu X., et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol: 2003; 180 6 1547 1555 (Pubitemid 36687082)
72. Lu M. D., Xu H. X., Xie X. Y., et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a restrospective comparative study. J Gastroenterol: 2005; 40 11 1054 1060
73. Shibata T., Iimuro Y., Yamamoto Y., et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology: 2002; 223 2 331 337 (Pubitemid 34454307)
74. Poggi G., Montagna B., DI Cesare P., et al. Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. Anticancer Res: 2013; 33 3 1221 1227
75. Shibata T., Niinobu T., Ogata N., Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer: 2000; 89 2 276 284 (Pubitemid 30489874)
76. Tanaka K., Shimada H., Nagano Y., Endo I., Sekido H., Togo S. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery: 2006; 139 2 263 273 (Pubitemid 43170328)
77. Cammà C., Di Marco V., Orlando A., et al. Unità Interdipartimentale Neoplasie Epatiche (U.I.N.E) Group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol: 2005; 42 4 535 540 (Pubitemid 40342933)
78. Lencioni R., Cioni D., Crocetti L., et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology: 2005; 234 3 961 967 (Pubitemid 40250844)
79. Tateishi R., Shiina S., Teratani T., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer: 2005; 103 6 1201 1209 (Pubitemid 40328091)
80. Guglielmi A., Ruzzenente A., Sandri M., et al. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg: 2007; 11 2 143 149
81. Guglielmi A., Ruzzenente A., Battocchia A., Tonon A., Fracastoro G., Cordiano C. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology: 2003; 50 50 480 484 (Pubitemid 36390549)
82. Seror O., N'Kontchou G., Ibraheem M., et al. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes-initial experience in 26 patients. Radiology: 2008; 248 1 288 296
83. Kuang M., Lu M. D., Xie X. Y., et al. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna-experimental and clinical studies. Radiology: 2007; 242 3 914 924
84. Tiong L., Maddern G. J. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg: 2011; 98 9 1210 1224
85. Lin S. M., Lin C. J., Lin C. C., Hsu C. W., Chen Y. C. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut: 2005; 54 8 1151 1156
86. O'Rourke A. P., Haemmerich D., Prakash P., Converse M. C., Mahvi D. M., Webster J. G. Current status of liver tumor ablation devices. Expert Rev Med Devices: 2007; 4 4 523 537 (Pubitemid 47050199)
87. Erinjeri J. P., Clark T. W. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol: 2010; 21 (8, Suppl): S187 S191
88. Bryant G. DSC measurement of cell suspensions during successive freezing runs: implications for the mechanisms of intracellular ice formation. Cryobiology: 1995; 32 2 114 128
89. Baust J. G., Gage A. A. The molecular basis of cryosurgery. BJU Int: 2005; 95 9 1187 1191 (Pubitemid 40799427)
90. Finelli A., Rewcastle J. C., Jewett M. A. Cryotherapy and radiofrequency ablation: pathophysiologic basis and laboratory studies. Curr Opin Urol: 2003; 13 3 187 191 (Pubitemid 36571006)
91. Weber S. M., Lee F. T. Jr, Chinn D. O., Warner T., Chosy S. G., Mahvi D. M. Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model. Surgery: 1997; 122 4 742 747 (Pubitemid 27452585)
92. Sheen A. J., Poston G. J., Sherlock D. J. Cryotherapeutic ablation of liver tumours. Br J Surg: 2002; 89 11 1396 1401
93. Xu K. C., Niu L. Z., Zhou Q., et al. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol: 2009; 15 29 3664 3669
94. Adam R., Hagopian E. J., Linhares M., et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg: 2002; 137 12 1332 1339, discussion 1340
95. Pearson A. S., Izzo F., Fleming R. Y., et al. Intraoperative radiofrequency ablation or cryoablation for hepatic maligancies. Am J Surg: 1999; 178 6 592 599 (Pubitemid 30058318)
96. Seifert J. K., Morris D. L. World survey on the complications of hepatic and prostate cryotherapy. World J Surg: 1999; 23 2 109 113, discussion 113-114
97. Sheen A. J., Siriwardena A. K. The end of cryotherapy for the treatment of nonresectable hepatic tumors? Ann Surg Oncol: 2005; 12 3 202 204 (Pubitemid 40568905)